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OBJECTIVES The study investigated the clinical significance and mechanism of orthostatic blood pressure
(BP) dysregulation in elderly hypertensive patients.
BACKGROUND Although orthostatic hypotension (OHYPO), often found in elderly hypertensive patients,
has been recognized as a risk factor for syncope and cardiovascular disease, both the clinical
significance and the mechanism of orthostatic hypertension (OHT) remain unclear.
METHODS We performed a head-up tilting test and brain magnetic resonance imaging (MRI) in 241
elderly subjects with sustained hypertension as indicated by ambulatory BP monitoring. We
classified the patients into an OHT group with orthostatic increase of systolic blood pressure
(SBP) of 20 mm Hg (n  26), an OHYPO group with orthostatic SBP decrease of 20
mm Hg (n  23), and a normal group with neither of these two patterns (n  192).
RESULTS Silent cerebral infarcts were more common in the OHT (3.4/person, p  0.0001) and
OHYPO groups (2.7/person, p  0.04) than in the normal group (1.4/person). Morning
SBP was higher in the OHT group than in the normal group (159 vs. 149 mm Hg, p 
0.007), while there were no significant differences of these ambulatory BPs between the two
groups during other periods. The OHT (21 mm Hg, p 0.0001) and OHYPO (20 mm Hg,
p  0.01) groups had higher BP variability (standard deviation of awake SBP) than the
normal group (17 mm Hg). The associations between orthostatic BP change and silent
cerebrovascular disease remained significant after controlling for confounders, including
ambulatory BP. The orthostatic BP increase was selectively abolished by alpha-adrenergic
blocking, indicating that alpha-adrenergic activity is the predominant pathophysiologic
mechanism of OHT.
CONCLUSIONS Silent cerebrovascular disease is advanced in elderly hypertensives having OHT. Elderly
hypertensives with OHT or OHYPO may have an elevated risk of developing hypertensive
cerebrovascular disease. (J Am Coll Cardiol 2002;40:133–41) © 2002 by the American
College of Cardiology Foundation
In normal subjects, because of an autoregulatory mecha-
nism, the blood pressure (BP) shows minimal variation with
posture-dependent changes. In most hypertensive patients
without autonomic nervous dysfunction, the postural BP
changes are also minimal. Orthostatic hypotension
(OHYPO), often found in elderly hypertensives, is well
recognized as a risk for falls, syncope and cardiovascular
events (1–4). In contrast, there have been few reports on
orthostatic hypertension (OHT), in which the BP increases
with orthostatic postural change (5–9). Although two pre-
vious reports suggested that an orthostatic BP increase
predicts an increased risk of developing coronary artery
disease (CAD) (5,7), the clinical significance and mecha-
nism of OHT remain unclear.
We performed a head-up tilting test (HUT), ambulatory
blood pressure monitoring (ABPM) and brain magnetic
resonance imaging (MRI), which is the most sensitive
method of detecting silent cerebrovascular disease, in 241
asymptomatic elderly hypertensives.
METHODS
Patients. We initially enrolled 244 elderly hypertensive
outpatients (age 60 years) who satisfied the following
criteria: 1) essential hypertension with average clinic BP
(measured within one week before ABPM by standard cuff
methods after resting for at least 5 min while seated) on 2
occasions at separate visits 140 mm Hg for systolic blood
pressure (SBP) and/or 90 mm Hg for diastolic blood
pressure (DBP); and 2) average 24-h SBP 130 mm Hg or
DBP 80 mm Hg (10). Thus, patients with white-coat
hypertension were excluded (10); previous research showed
that the prevalence of silent cerebral infarct (SCI) and risk
of stroke in white-coat hypertensives are comparable to
those in normotensives (11–13). These patients were en-
rolled from the three participating clinics between April
1996 and August 2000, and 188 patients in the present
study were included in our previous study (13,14). No
patient had received any antihypertensive medication for at
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least 14 days before the study. After physical and laboratory
examinations, we excluded patients with renal failure (serum
creatinine level 130 mmol/l), hepatic damage present
illness, or a past history of coronary artery disease (CAD)
stroke, congestive heart failure, arrhythmia or other serious
medical conditions. Patients with symptomatic OHYPO
with SBP decrease30 mm Hg 1 min after active standing,
and those with possible diabetes mellitus (fasting glucose
5.5 mmol/l and/or hemoglobin A1c 6.0%), were also
excluded. This study was approved by the Research Ethics
Committee, Department of Cardiology, Jichi Medical
School, and informed consent was obtained from each
subject.
The body mass index was calculated as weight (kg)/
height (m)2. Electrocardiographically verified left ventricu-
lar hypertrophy (ECG-LVH) was defined by abnormally
high voltages of QRS complexes (RV5  SV1 3.5 mV)
associated either with flat T waves (10% of R) or with
ST-segment depression and biphasic T waves.
HUT and definition of OHT and OHYPO. After BP
and pulse rate (PR) were measured with an interval of 1 min
at baseline and after the subjects had been in a supine
position for at least 10 min, they were positioned upright on
a tilt table at an angle of 70° for 15 min. Three patients who
developed presyncope during HUT were excluded from this
study, and the remaining 241 patients were studied further.
Orthostatic BP and PR changes were calculated as: the
average during 6 to 10 min during tilting minus the average
in the supine position during the 1 to 5 min just before the
tilting (9). We classified the patients into an OHT group
with orthostatic SBP increase 20 mm Hg (n  26), an
OHYPO group with orthostatic SBP decrease20 mm Hg
(n  23) and an orthostatic normotension group (ONT)
with neither of these two patterns (n  192).
ABPM. After HUT, ABPM was carried out on a weekday
with an automatic ABPM device employing the oscillomet-
ric method (ABPM-6307s, NipponColin, Komaki, Japan;
TM-2421, TM-2425, A&D, Tokyo, Japan); this device
recorded BP and PR every 30 min for 24 h. Based on each
patient’s diary, sleep BP was defined as the average BP from
the time when the patient went to bed until the time he or
she got out of bed, and awake BP as the average of BPs
during the remainder of the day. The standard deviation of
awake BPs of each patient was calculated. Morning BP was
defined as the average BP during 2 h (4 to 5 points) after the
time of awakening.
Brain MRI. Brain MRI was performed using a supercon-
ducting magnet with a main strength of 1.5 T (Toshiba
MRT200FXII, Toshiba; SIGNA Horizon Ver. 5.8, Gen-
eral Electric, Vision, Siemens) within three months before
or after ABPM. The T1- and T2-weighted images were
obtained in the transverse plane with 7.8- to 8.0-mm-thick
sections. The MRI images of the subjects were randomly
stored and interpreted blind to the subjects’ names and
characteristics, as reported previously (13,14), and they were
evaluated for subcortical infarcts and deep white matter
(DWM) lesions. An SCI was defined as a low-signal-
intensity area (3 to 15 mm) on T1-weighted images that
was also visible as a hyperintense lesion on T2-weighted
images (11–14). Multiple SCIs were defined as 3 infarcts/
person. Advanced DWM lesion was defined as detection of
hyperintense multiple punctate lesions or such lesions at the
early confluent stage or those that had reached confluency in
the DWM area on T2-weighted images.
Neurohumoral factors. Blood collection was performed
after 10 min in the supine position just before the tilting,
and after 15-min of tilting in 87 consecutive patients
enrolled between June 1, 1996, and July 1998. All of these
patients were included in the entire study population (n 
241) (Table 1). Blood samples were immediately centri-
fuged at 3,000 rpm for 15 min, and plasma was decanted
and stored at 80°C until analysis. Catecholamines were
measured with high-pressure liquid chromatography (Hita-
chi, Tokyo, Japan). Plasma renin activity was determined
using a radioimmunoassay for angiotensin-I (PRA-SRL;
SRL, Tokyo, Japan). Vasopressin was determined using a
competitive radioimmunoassay (Mitsubishi Kagaku, Tokyo,
Japan). All these assays were performed at the Special
Reference Laboratory (Tokyo, Japan), and the intra-/
intercoefficient of variation was 0.81% 2.2% for the norepi-
nephrine assay, 0.85%/2.1% for the epinephrine assay,
6.8%/6.6% for the renin activity assay and 1.7%/3.9% for
the vasopressin assay.
Reproducibility of OHT and alpha-adrenergic blocking
effect. To investigate the reproducibility of OHT and the
role of alpha-adrenergic activity in the mechanism of OHT,
we administered selective alpha1-blocker to the 55 hyper-
tensives without OHYPO diagnosed by the first HUT. The
patients for this substudy were enrolled between June 1,
1996, and July 1998, and all the initial baseline data of these
patients were also included in the entire study data (n 
241) (Table 1) After the first ABPM and HUT, each
patient was studied for a maximum of 11 weeks, with an
observation period of three to five weeks, a titration period
Abbreviations and Acronyms
ABPM  ambulatory blood pressure monitoring
BP  blood pressure
CAD  coronary artery disease
DBP  diastolic blood pressure
DWM  deep white matter
ECG-LVH  electrocardiographically verified left
ventricular hypertrophy
HUT  head-up tilting test
MRI  magnetic resonance imaging
OHYPO  orthostatic hypotension
OHT  orthostatic hypertension
ONT  orthostatic normotension
OR  odds ratio
PR  pulse rate
RR  relative risk
SBP  systolic blood pressure
SCI  silent cerebral infarct
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of up to four weeks, and 1 to 5 weeks of maintenance. After
the observation period, patients were started on 1 mg of
doxazosin daily, taken at bedtime. The dose was doubled at
weekly intervals until the following BP reduction had been
achieved: the average seated BP had fallen: 1) by 20/10
mm Hg from the baseline level, or 2) by 10/5 mm Hg
from the baseline level when baseline BP160/90 mm Hg.
The dose was not increased further if the BP reduction
described above was achieved at each of two consecutive
visits, or a maximum daily dose of 8 mg of doxazosin had
been reached. After the titration phase, there was a main-
tenance phase of one to five weeks on the same dose of
doxazosin. This protocol was modified from that of the
Hypertension And Lipid Trial (15,16). The second HUT
was performed at the end of the drug-free baseline obser-
vation period (three to five weeks) just after the first HUT;
and the third was performed at the end of the maintenance
period (one to five weeks). The intervals between the first
and second HUTs, and between the second and third
HUTs, were three to five weeks and four to six weeks,
respectively.
Statistical analysis. One-way analysis of variance was per-
formed to evaluate differences among groups, Tukey’s hon-
estly significant difference test was used for comparison of
the mean values for pairs of groups, and the chi-square test
was used to detect among-group differences in prevalence
rates. Unpaired t tests and paired t tests were used for
comparison of the mean values for two different groups.
Changes of BP or PR from the baseline values were
analyzed using paired t tests for each group. Adjusted odds
ratio (OR) and 95% confidence intervals were calculated
using logistic regression analysis. Differences with p  0.05
(two-tailed) were considered statistically significant.
RESULTS
Clinical and BP characteristics. The OHT group was
older and showed a greater frequency of ECG-LVH than
the ONT group (Table 1) The other characteristics did not
differ significantly among the groups, although fewer OHT
subjects tended to have previously been on antihypertensive
medication when compared with the ONT group (p 
0.06). In the HUT, in comparison with the normal group,
supine SBP was significantly higher in the OHYPO group,
whereas SBP during tilting was higher in the OHT group.
No significant differences were seen in the orthostatic PR
profiles among the groups.
No significant differences existed in the levels of clinic
BPs or ambulatory BPs, except for sleep DBP, among the
groups (Table 2). Morning SBP was significantly higher
(p  0.007) and morning DBP tended to be higher (p 
0.09) in the OHT than in the ONT group. The sleep/
awake BP ratio was significantly lower in the OHT than in
Table 1. Clinical and BP Characteristics
Characteristics
Orthostatic
Hypertension
(n  26)
Normal Group
(n  192)
Orthostatic
Hypotension
(n  23)
Age (yrs) 75 (5.5)† 71 (6.5) 72 (6.2)
Male (%) 42 44 39
Body mass index (kg/m2) 22.9 (3.9) 23.6 (3.3) 22.9 (2.8)
Current smoker (%) 38 21 30
Hyperlipidemia (%) 23 20 30
Duration of hypertension (yrs) 6.5 (6.6) 6.4 (7.0) 7.9 (8.9)
Previous antihypertensive medication (%) 27 46 43
ECG-LVH (%) 46† 23 43
Clinic SBP (mm Hg) 165 (23) 159 (17) 166 (19)
Clinic DBP (mm Hg) 93 (17) 90 (14) 91 (12)
PR (beats/min) 76 (14) 75 (11) 70 (10)
Head-up tilting
SBP (mm Hg)
Supine 130 (17) 137 (17) 152 (20)*‡
During tilting 157 (16)* 137 (18) 128 (21)‡
Change 27 (8.9)* 0.50 (8.9) 24 (6.0)*‡
DBP (mm Hg)
Supine 71 (11)* 80 (9.6) 83 (10)‡
During tilting 86 (9.7) 83 (11) 79 (16)
Change 15 (6.6)* 3.5 (7.3) 4.1 (6.0)*‡
PR (beats/min)
Supine 67 (8.8) 69 (9.6) 65 (8.5)
During tilting 77 (12) 79 (11) 71 (7.8)
Change 9.2 (5.4) 7.1 (5.2) 8.0 (5.4)
Data are shown as the mean (standard deviation) or percentage. *p  0.001; †p  0.05 vs. normal group; ‡p  0.001 vs.
orthostatic hypertension group by Tukey’s honestly significant difference test after analysis of variance or 2test.
BP  blood pressure; DBP  diastolic blood pressure; ECG-LVH  left ventricular hypertrophy diagnosed by
electrocardiography; PR  pulse rate; SBP  systolic blood pressure.
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the OHYPO group. Concerning abnormal diurnal BP
variation patterns, the extreme-dipping pattern of nocturnal
BP (sleep/awake SBP ratio 0.8) was more common in the
OHT than in the ONT group (35% vs. 13%, p  0.004),
whereas the nocturnal BP rising pattern (sleep/awake SBP
ratio 1.0) was more common in the OHYPO than in the
ONT group (26% vs. 9.4%, p  0.016). The levels and SDs
of both awake SBP and DBP were higher in the OHT than
in the ONT group. The SD of awake SBP was also higher
in OHYPO than in ONT patients.
Silent cerebrovascular disease. The number of SCIs and
the prevalence of SCIs were significantly higher in both
OHT and OHYPO groups subjects than in the ONT group
(Table 3). Advanced DWM lesions were also significantly
more common in the OHT than in the ONT group. These
associations remained significant after adjusting for demo-
graphic characteristics and ambulatory BPs.
Because the definitions of OHT and OHYPO are arbi-
trary, we next empirically grouped the 241 study patients
into quintiles (Q1 to Q5) of orthostatic SBP increase. The
ORs for SCI and multiple SCIs after adjusting for demo-
graphics and ambulatory BP showed a U-shaped relation-
ship (Fig. 1).
Neurohumoral factors. The plasma norepinephrine level
during tilting was significantly higher (778 vs. 577 pg/ml,
p  0.04) and its orthostatic increase tended to be higher
(351 vs. 245 pg/ml, p 0.06) in the OHT than in the ONT
group, whereas the supine norepinephrine tended to be
higher in the OHYPO (p  0.07) group (Table 4). Plasma
vasopressin after tilting was higher in the OHT than in the
ONT (p 0.04) and the OHYPO (p 0.009) groups. The
orthostatic vasopressin increase tended to be higher in
OHT subjects than in OHYPO subjects (p  0.06). The
orthostatic renin profile was comparable in the three groups.
Reproducibility. The correlation coefficients of the ortho-
static BP increases in the first HUT and second HUT were
0.61 for SBPs and 0.47 for DBPs (both p  0.001) in the
55 hypertensives. Of the 13 OHT patients with orthostatic
SBP increase of 20 mm Hg in the first HUT, 10 (77%)
had an orthostatic SBP increase of 10 mm Hg, and 5
(38%) had a 20 mm Hg increase, in the second HUT.
Effect of alpha-adrenergic blocking. When we defined
the OHT on the basis of the average orthostatic SBP
increase of the first and second HUTs, 10 patients were
classified into the OHT and 45 patients into the ONT
group. Figure 2 shows the effect of alpha-adrenergic block-
ing on orthostatic BP change in each group. In the ONT
group, alpha-blocking reduced baseline and orthostatic BPs.
In the OHT group, alpha-blocking reduced only orthostatic
BP, while baseline BP was not significantly affected. Or-
thostatic SBP tended to be more markedly reduced in the
OHT than in the ONT group (23 vs. 14 mm Hg, p 
0.09). The orthostatic BP increase was more markedly
attenuated in the OHT than in the ONT group (p  0.01).
DISCUSSION
In the present study, we examined asymptomatic hyperten-
sive subjects without previous or currently active cardiovas-
cular disease because the orthostatic BP regulation might be
Table 2. Ambulatory Blood Pressure Characteristics
Measures
Orthostatic Hypertension
(n  26)
Normal Group
(n  192)
Orthostatic Hypotension
(n  23)
SBP
Awake (mm Hg) 153 (15) 149 (13) 150 (14)
Sleep (mm Hg) 132 (18) 133 (16) 138 (15)
Morning (mm Hg) 159 (18)† 149 (16) 150 (14)
24 h (mm Hg) 145 (12) 143 (12) 146 (12)
SD of awake SBP (mm Hg) 21 (5.0)* 17 (4.6) 20 (5.2)†
Sleep/awake ratio 0.86 (0.11) 0.89 (0.08) 0.93 (0.10)§
DBP
Awake (mm Hg) 85 (7.6) 87 (8.6) 86 (8.1)
Sleep (mm Hg) 72 (9.1)‡ 77 (9.6) 76 (9.6)
Morning (mm Hg) 93 (6.9) 89 (10) 87 (8.8)
24 h (mm Hg) 80 (6.4) 84 (8.1) 83 (7.7)
SD of awake DBP (mm Hg) 14 (3.8)‡ 12 (2.9) 13 (2.3)
Sleep/awake ratio 0.85 (0.09) 0.89 (0.09) 0.91 (0.10)§
Data are shown as the mean (standard deviation [SD]) or percentage.
*p  0.001; †p  0.01; ‡p  0.05 vs. normal group; §p  0.05 vs. orthostatic hypertension group.
DBP  diastolic blood pressure; SBP  systolic blood pressure.
Table 3. Silent Cerebrovascular Disease
Measures
Orthostatic
Hypertension
(n  26)
Normal
Group
(n  192)
Orthostatic
Hypotension
(n  23)
SCI
Prevalence (%) 81† 48 74
Average number/person 3.4 (2.8)* 1.4 (2.3) 2.7 (2.0)‡
Multiple cerebral infarcts§
Prevalence (%) 65* 24 65*
Advanced DWM lesion
Prevalence (%) 62† 31 35
Data are shown as the mean (standard deviation) or percentage.
*p 0.001; †p 0.01; ‡p 0.05 vs. normal group. §Defined as 3 silent infarcts
(person).
DWM  deep white matter; SCI  silent cerebral infarct.
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altered in patients with overt cardiovascular disease. The
prevalence of SCI in elderly hypertensives in this study was
54%, and this value is higher than the values reported in
previous studies using brain MRI (41% to 53%) (11,12,17,18),
probably due to the exclusion here of white-coat hyperten-
sion.
Our main findings were that OHT, as well as OHYPO,
is found fairly frequently in elderly Japanese patients with
sustained hypertension, and that such patients with OHT
have markedly advanced silent cerebrovascular disease. This
study provides new evidence indicating that a U-curve
relationship exists between orthostatic BP change and
hypertensive cerebrovascular disease in the elderly.
Orthostatic BP dysregulation and cerebrovascular disease.
The number of SCIs and the prevalence of all silent
cerebrovascular diseases (SCI, multiple SCIs and advanced
DWM lesion) were significantly higher in the OHT than in
the ONT group. Multiple SCIs were more common in the
OHYPO than in the ONT group. These associations found
in our elderly patients with sustained hypertension were
previously also found in community-dwelling Japanese el-
derly subjects 75 years old (8), for whom the mean SCI
per person was 3.6 in 10 OHYPO subjects (orthostatic SBP
decrease 20 mm Hg), and 3.5 in 10 subjects with OHT
(orthostatic SBP increase 20 mm Hg). These mean
numbers of SCIs in both groups were significantly higher
than the 2.1 in 20 ONT subjects with orthostatic BP
increase of 20 to 20 mm Hg (both p  0.05). In that
study (8), posture-dependent BP change was assessed after
active standing for 2 min. In the present study, HUT was
performed to assess orthostatic BP dysregulation more
precisely. Because the definitions of OHT and OHYPO
were arbitrary, we empirically grouped the study patients
into quintiles of orthostatic SBP increase and found a
U-shaped relation between the orthostatic SBP change and
silent cerebrovascular disease after controlling for other
confounding factors, including ambulatory BP levels. This
association was especially marked for multiple SCIs.
There have been no reports showing an association
between OHT and cardiovascular events. A recent large
population-based prospective study, the Atherosclerosis
Risk In Communities study, disclosed that OHYPO is an
Figure 1. U-curve relationship between orthostatic blood pressure (BP) change and silent cerebral infarcts in elderly subjects with sustained hypertension.
The odds ratios (mean and 95% confidence interval [CI]) for silent cerebral infarcts: (A: 0 subjects with no infarct; 1 subjects with one or more infarcts)
or for silent multiple cerebral infarcts (B: 0  subjects with fewer than 3 infarcts; 1  subjects with three or more infarcts) were adjusted for age (years),
gender (0  female, 1  male), body mass index (kg/m2), smoking status (0  nonsmoker, 1  current smoker), presence/absence of hyperlipidemia (0 
none, 1  present), and 24-h systolic BP (mm Hg) using multiple logistic regression analysis (Q3  the reference group).
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independent risk factor for both stroke (relative risk [RR]
2.0) (3) and CAD (RR  3.5) (4). However, that study
population consisted of middle-aged subjects, and the asso-
ciation between OHT and cardiovascular events was not
examined.
Another prospective study on elderly men 70 years old
showed that OHYPO was a risk for total mortality with an
RR of 1.64 (2). In that study, a U-curve relationship was not
found, but those investigators did not study the cardiovas-
cular events separately. Silent cerebral infarct, which is now
classified as a cerebrovascular disorder, type III, by the
National Institute of Neurological Disorders and Stroke,
has been proposed to be a predisposing condition for
subsequent overt stroke. In fact, SCI is a potent predictor of
future stroke, with an RR of about 5, in elderly hyperten-
sives (13), and with an RR of about 10 in all adults (19).
Thus, OHT may be a risk factor for future clinical stroke in
elderly hypertensives.
Mechanism of orthostatic BP dysregulation in silent
cerebrovascular disease. The mechanism of the associa-
tion between orthostatic BP dysregulation (OHT and
OHYPO) and silent cerebrovascular disease remains un-
clear. In addition, whether orthostatic BP dysregulation is a
result or cause of silent cerebrovascular disease is not known.
The fact that the OHT subjects had a significantly higher
frequency of ECG-LVH in addition to being older (two
significant cerebrovascular risk factors) may be the reason
why they also had advanced silent cerebrovascular disease.
In addition, somewhat fewer OHT subjects had previously
been on antihypertensive medication, which might have
altered baroreceptor response. However, even after control-
ling for these factors, the association between orthostatic BP
dysregulation and silent cerebrovascular disease remained
significant.
Autonomic nervous activity may be affected by cerebral
infarction (20). Thus, one explanation for the association is
that patients with more long-standing hypertension or more
severe hypertension suffer greater degrees of silent cerebro-
vascular disease, leading to autonomic nervous dysfunction
and orthostatic BP dysregulation. However, no significant
differences existed among the OHT and the other two
groups in the hypertension duration, previous antihyperten-
sive therapy or ambulatory BP level. In further support of
autonomic dysregulation in patients with OHT, OHYPO
and cerebrovascular disease is the observation in Table 2
that BP variability was greater in these groups.
Increased morning BP might have contributed to the
increase in the risk for silent cerebrovascular disease in the
OHT group. Morning BP increase is reported to be
associated with cardiac hypertrophy in hypertensive patients
(21), and this may trigger cardiovascular events (22). The-
oretically, orthostatic BP increase due to upright position
after awakening could partly contribute to ambulatory
morning BP. In fact, in our study, morning BP level was
significantly higher in the OHT than in the ONT group.
Another possibility is that, particularly in elderly hyper-
tensives with reduced cerebrovascular reserve capacity, fre-
quent episodes of increased BP variability during daily
activity might advance silent cerebrovascular disease. In
addition, previous studies using brain MRI disclosed that
elderly hypertensives with postprandial hypotension (23)
and extreme-dipping of nocturnal BP (14) have more
advanced hypertensive cerebrovascular disease. In elderly
hypertensives, these relative hypotensive conditions (OHT
and OHYPO, postprandial hypotension and extreme-
dipping of nocturnal BP) increase the ambulatory BP
variability, leading to silent and clinically overt cerebrovas-
cular disease (24). In the present study, extreme-dipping
status of nocturnal BP was more common in the OHT
group, whereas the nocturnal BP rising pattern was more
common in the OHYPO group. In addition, ambulatory
BP variability (standard deviation of awake SBP) was
increased in both the OHT and OHYPO groups compared
with the ONT group. A recent prospective study (25)
showed that increased postural BP variability is significantly
associated with stroke prognosis in elderly nursing home
residents. Thus, a hemodynamic mechanism might partly
account for the association between orthostatic BP dysregu-
lation and silent cerebrovascular disease in elderly hyperten-
sives.
A recent population-based prospective study demon-
strated that men with exaggerated stress-induced SBP
response (20 mm Hg) had 87% greater risk of ischemic
stroke than less reactive men (26). Thus, excessive sympa-
thetic reactivity to stress may be etiologically important for
silent and clinical hypertensive cerebrovascular disease.
Racial difference. Silent OHYPO in elderly hypertensives
(9.5%) is unexpectedly less common among Japanese than in
Western populations, where OHYPO is reported to occur
in up to 20% to 30% of elderly hypertensives (1). Defined as
Table 4. Neurohumoral Profiles
Measures
Orthostatic
Hypertension
(n  16)
Normal
Group
(n  66)
Orthostatic
Hypotension
(n  5)
Norepinephrine (pg/ml)
Supine 427 (138) 332 (203) 526 (87)
15-min during tilting 778 (259)* 577 (307) 788 (223)
Orthostatic increase 351 (175) 245 (167) 261 (142)
Epinephrine (pg/ml)
Supine 30 (17) 31 (29) 42 (21)
15-min during tilting 58 (33) 52 (46) 73 (32)
Orthostatic increase 28 (22) 21 (27) 31 (12)
Renin activity (ng/ml/h)
Supine 0.50 (0.35) 0.57 (0.55) 0.34 (0.22)
15-min during tilting 0.65 (0.45) 0.85 (0.74) 0.36 (0.18)
Orthostatic increase 0.15 (1.8) 0.28 (0.29) 0.02 (0.08)
Vasopressin (pg/ml)
Supine 2.2 (1.5) 1.8 (1.1) 1.3 (0.40)
15-min during tilting 3.7 (2.1)* 2.7 (1.3) 1.4 (0.65)†
Orthostatic increase 1.5 (1.6) 0.92 (1.0) 0.13 (0.74)
Data are shown as the mean (standard deviation).
*p  0.05 vs. normal group; †p  0.01 vs. orthostatic hypertension group.
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an orthostatic SBP increase of 20 mm Hg, OHT (11%) is
found more frequently than OHYPO among elderly Japa-
nese hypertensives. This orthostatic BP change might re-
flect a racial difference in the cardiovascular system response
between Japanese and Westerners. This speculation may be
supported by the finding in a comparative study (27) that, in
elderly Japanese individuals, falling occurs at about one-
fourth of the incidence in the U.S. This difference might be
partly due to the Japanese lifestyle, in which customary
squatting behavior would preserve the muscle strength and
facilitate venous return from the lower extremities serving to
prevent orthostatic BP decrease. All of the elderly subjects
we studied engaged in this traditional Japanese form of
squatting.
Mechanism of OHT. The mechanism of OHT remains
unclear, although some pathogenic processes have been
reported (6). Plasma norepinephrine and vasopressin levels
during tilting were significantly higher and the orthostatic
norepinephrine increase tended to be higher in the OHT
than in the ONT group. In addition, morning BP, which
was more closely associated with alpha-adrenergic activity
than ambulatory BP during other periods (15,28), was
increased in the OHT group. The orthostatic BP increase in
the OHT group was diminished by alpha-adrenergic blockade.
The orthostatic PR profile was comparable among the three
groups. These findings suggest that orthostatic activation of
sympathetic activation, particularly for alpha-adrenergic activ-
ity, might play some role in the pathogenesis of OHT.
The fact that patients with OHT had a higher frequency
of ECG-LVH, as well as greater elevation in norepineph-
rine during tilting, suggests they may have congestive heart
failure. A further study using echocardiograms will be
necessary to confirm the presence of LVH or quantity the
degree of systolic or diastolic ventricular dysfunction in the
OHT patients.
Definition and reproducibility of OHT. As various factors
affect orthostatic BP change, the reproducibility of OHYPO is
relatively poor (29). The reproducibility of OHT when defined
Figure 2. Effect of alpha-adrenergic blocking on orthostatic blood pressure change. The dotted bars show the supine blood pressure (upper edge systolic
blood pressure; lower edge  diastolic blood pressure) and the solid bars show the orthostatic blood pressure during tilting test. The values within the
arrows show the orthostatic blood pressure change (systolic/diastolic) by tilting test. The baseline orthostatic blood pressure increase was significantly higher
in the orthostatic hypertension group than in the normal group (systolic blood pressure/diastolic blood pressure: 24/8.6 mm Hg vs. 1.5/2.5 mm Hg, both
p  0.01).
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using the cutoff value of 20 mm Hg for orthostatic SBP
increase was relatively poor in this study. In addition, the effect
of “regression to the mean” may partly explain the observed
orthostatic BP change, because the OHT group had the lowest
supine BP, and the OHYPO group had the highest.
To minimize the effect of “regression to the mean” in
defining OHT and OHYPO, we used the HUT (which
measures BP levels every min) instead of the routine active
standing test (sitting BP, and BPs 1 min and 3 min after
standing). If increased BP variability is the problem with
these patients, there will be days when they have supine
hypertension and OHYPO and other days when they will
have the reverse. Thus, ideally, the classification of OHT
and OHYPO groups would have been based on three or
more different postural BP measures. However, a significant
positive correlation existed between orthostatic BP change
in the first HUT and that in a second HUT performed
within the following three to five weeks in this study, and no
patients with OHT as indicated by the first HUT were
classified into the OHYPO group at the second HUT.
Thus, one HUT test seems to detect some individual charac-
teristics of orthostatic BP regulation. Conversely, the repeated
assessment of routine sitting and standing BP may be more
practical for defining the OHT and OHYPO conditions.
Further studies focusing on methods and reproducibility will
be necessary to establish an adequate definition of OHT.
Study limitations. As this study was cross-sectional, a
prospective study will be necessary in the future to strictly
address the causality between orthostatic BP dysregulation
and silent cerebrovascular disease. There is the possibility
that when hypertension causes subclinical cerebrovascular
disease in some specific brain area, BP variability increases
owing to autonomic nervous system dysfunction. In addi-
tion, there was no placebo control arm for our alpha-
adrenergic blocking study. Thus, to strengthen our conclu-
sion that alpha-adrenergic hyperactivity is the predominant
cause of OHT, a discontinuation study of alpha-adrenergic
blockade to confirm the development of OHT again, or a
plabebo-controlled study, will be necessary.
Conclusions. Given that elderly hypertensive patients with
OHT or OHYPO often have advanced silent cerebrovas-
cular disease, they may be at elevated risk of overt clinical
cerebrovascular events. Elderly hypertensive patients should
be followed with respect to orthostatic BP changes.
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